More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Imperative Care, Thrombolex, and more

    Momentum remains strong across MedTech as investors support companies developing advanced solutions in stroke intervention, robotics, and digital diagnostics. This week’s deals reflect a focus on technologies nearing clinical and commercial inflection points. Imperative Care...

    GS MedTech Funding Tracker – Imperative Care, Thrombolex, and more

    Momentum remains strong across MedTech as investors support companies developing advanced solutions in stroke intervention, robotics, and digital diagnostics. This week’s deals reflect a...

    Embecta to acquire Owen Mumford for up to $199.4M

    Embecta announced that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited. Owen Mumford, a privately held, UK-based company, develops and manufactures...

    Corcym reports first U.S. implantation of next-gen sutureless aortic valve

    Corcym has completed the first U.S. implantation of its next-generation Perceval Plus Lancelot sutureless aortic valve. The Perceval Plus Lancelot valve introduces a next-generation manufacturing...

    JenaValve wins FDA nod for Trilogy heart valve system

    JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system. Trilogy, a transcatheter heart valve (THV) system, won approval for the...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Imperative Care, Thrombolex, and more

    Momentum remains strong across MedTech as investors support companies developing advanced solutions in stroke intervention, robotics, and digital diagnostics. This week’s deals reflect a...

    Embecta to acquire Owen Mumford for up to $199.4M

    Embecta announced that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited. Owen Mumford, a privately held, UK-based company, develops and manufactures...

    Corcym reports first U.S. implantation of next-gen sutureless aortic valve

    Corcym has completed the first U.S. implantation of its next-generation Perceval Plus Lancelot sutureless aortic valve. The Perceval Plus Lancelot valve introduces a next-generation manufacturing...

    JenaValve wins FDA nod for Trilogy heart valve system

    JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system. Trilogy, a transcatheter heart valve (THV) system, won approval for the...

    M&A

    Archives

    Latest articles